Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on April 13, 2005
J Am Soc Nephrol 16: 1673-1683, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004050374

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004050374v1
16/6/1673    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández-Vargas, P.
Right arrow Articles by Gómez-Guerrero, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández-Vargas, P.
Right arrow Articles by Gómez-Guerrero, C.

Hemodynamics and Vascular Regulation

Suppressors of Cytokine Signaling Regulate Angiotensin II-Activated Janus Kinase-Signal Transducers and Activators of Transcription Pathway in Renal Cells

Purificación Hernández-Vargas*, Oscar López-Franco*, Guillermo Sanjuán*, Mónica Rupérez*, Guadalupe Ortiz-Muñoz*, Yusuke Suzuki{ddagger}, Pablo Aguado-Roncero{dagger}, Gloria Pérez-Tejerizo{dagger}, Julia Blanco§, Jesús Egido*, Marta Ruiz-Ortega* and Carmen Gómez-Guerrero*

* Renal and Vascular Research Laboratory, {dagger} Pediatric Surgery Department, Fundación Jiménez Díaz, Autonoma University, Madrid, Spain; {ddagger} Division of Nephrology, Department of Internal Medicine, Juntendo University, Tokyo, Japan; and § Department of Pathology, Hospital Clínico San Carlos, Madrid, Spain

Address correspondence to: Dr. Carmen Gómez-Guerrero, Renal and Vascular Research Laboratory, Fundación Jiménez Díaz, Avda Reyes Católicos 2, Madrid, Spain 28040. Phone: 34-91-5504800; Fax: 34-91-5442636; E-mail: cgomez{at}fjd.es

Received for publication May 11, 2004. Accepted for publication February 28, 2005.

Suppressors of cytokine signaling (SOCS) family is constituted by cytokine-inducible proteins that modulate receptor signal transduction via tyrosine kinases, mainly the Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway. Differential SOCS expression was noted in renal cells that were incubated with inflammatory stimuli, but the role of SOCS in the pathogenesis of renal diseases is not yet well defined. Because angiotensin II (Ang II) plays a key role in renal disease, SOCS proteins were studied as a novel mechanism involved in the negative regulation of Ang II-mediated processes. Systemic Ang II infusion for 3 d increased the renal mRNA expression of SOCS-3 and SOCS-1. SOCS protein synthesis was found in glomerular mesangial area and tubules. In cultured mesangial cells and tubular epithelial cells, Ang II induced a rapid and transient SOCS-3 and SOCS-1 expression in parallel with JAK2 and STAT1 activation. In both cell types, overexpression of SOCS proteins prevented the STAT activation in response to Ang II. SOCS expression observed in Ang II-infused rats and in Ang II-stimulated cells was significantly inhibited by treatment with AT1 but not AT2 receptor antagonist and was attenuated in mesangial cells from AT1a-deficient mice, demonstrating the implication of AT1 in those responses. In SOCS-3 knockdown studies, antisense oligonucleotides inhibited the expression of SOCS-3 and increased the Ang II-induced STAT activation and c-Fos/c-Jun expression, then resulting in a more severe renal damage. These results suggest that SOCS proteins may act as negative regulators of Ang II signaling in renal cells and implicate SOCS as important modulators of renal damage.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
T. Hidaka, Y. Suzuki, M. Yamashita, T. Shibata, Y. Tanaka, S. Horikoshi, and Y. Tomino
Amelioration of Crescentic Glomerulonephritis by RhoA Kinase Inhibitor, Fasudil, through Podocyte Protection and Prevention of Leukocyte Migration
Am. J. Pathol., March 1, 2008; 172(3): 603 - 614.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP